58 results match your criteria Jessner Lymphocytic Infiltration of the Skin


Lymphoma or pseudolymphoma: A report of six cases and review of the literature.

Dermatol Ther 2019 07 7;32(4):e12807. Epub 2019 Jan 7.

Department of Dermatology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

To explore and compare the clinical presentations and pathologic features of cutaneous pseudolymphomas (CPL) with primary cutaneous lymphomas. Review literature in order to improve the treatment of CPL. Six cases of CPLs were collected. Read More

View Article and Full-Text PDF

Jessner-Kanof lymphocyte infiltration responded well to impulse intralesional corticosteroid.

Dermatol Ther 2018 11 8;31(6):e12730. Epub 2018 Oct 8.

Department of Dermatology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.

View Article and Full-Text PDF
November 2018

Jessner lymphocytic infiltration - rare in childhood.

Dermatol Online J 2017 Oct 15;23(10). Epub 2017 Oct 15.

Department of Dermatology and Allergy Centre, Odense University Hospital, Denmark.

We present a 13-year-old girl with Jessner lymphocytic infiltrate of the skin, who has suffered from the disease since the age of 9 years. It is a rare disease in childhood, and we highlight the clinical features and therapeutic response of tacrolimus. Read More

View Article and Full-Text PDF
October 2017

Etanercept-Induced Lymphocytic Infiltration of Jessner-Kanof.

Arthritis Rheumatol 2018 03 10;70(3):449. Epub 2018 Jan 10.

Centre Hospitalier de Valenciennes, Valenciennes, France.

View Article and Full-Text PDF

The Histopathological Spectrum of Pseudolymphomatous Infiltrates in Cutaneous Lupus Erythematosus.

Am J Dermatopathol 2018 Apr;40(4):247-253

Research Unit Dermatopathology, Department of Dermatology, Medical University of Graz, Graz, Austria.

The occurrence of pseudolymphomatous infiltrates in cutaneous lupus erythematosus (cLE) is described mainly in lupus panniculitis and lupus tumidus/lymphocytic infiltration of the skin (Jessner-Kanof). We collected 15 cases of pseudolymphomatous cLE other than lupus panniculitis and lupus tumidus (M:F = 4:11; age range: 23-79 years; mean age: 50.9 years; median age: 57 years). Read More

View Article and Full-Text PDF

Mepacrine as successful monotherapy for refractory Jessner-Kanof disease: still an important drug in the dermatologic armamentarium.

J Dermatolog Treat 2017 May 10;28(3):276-278. Epub 2016 Aug 10.

a Department of Dermatology , University Hospital Antwerp (UZA), University of Antwerp (UA) , Antwerp , Belgium.

Introduction: Jessner-Kanof disease (JKD), a lymphocytic infiltration of the skin, can be difficult to treat. Mepacrine (quinacrine), an anti-malarial less available in Belgium, may be beneficial.

Patients And Methods: Two female patients with biopsy-proven and therapy-resistant JKD, not responding to topical and systemic corticosteroids, (hydroxy-)chloroquine and/or dapsone, were treated with mepacrine 100 mg daily. Read More

View Article and Full-Text PDF

Unilateral unique Lupus tumidus: pathogenetic mystery and diagnostic problem.

Wien Med Wochenschr 2016 May 13;166(7-8):250-3. Epub 2016 Jan 13.

Policlinic for Dermatology and Venereology, University Hospital Lozenetz, Koziak street 1, 1407, Sofia, Bulgaria.

Lupus tumidus is a rare immunological disorder whose pathogenesis is not fully understood. Although on the one hand there are some differences in (1) the clinical morphology of lesions, (2) the histopathology picture, as well as in (3) serological profile of lupus tumidus patients at the current moment, the disease is regarded as a subform of chronic cutaneous lupus erythematosus. Differential diagnosis requires the exclusion of many diseases such as Jessner Kanoff lymphocytic infiltration, polymorphous light eruption, and reticular erythematous mucinosis. Read More

View Article and Full-Text PDF

Duloxetine-induced pseudolymphoma with features of lymphocytic infiltration of Jessner-Kanof.

Acta Derm Venereol 2014 Sep;94(5):605-6

Department Medical Sciences, Section of Dermatology, University of Ferrara, Via Savonarola 9, IT-44123 Ferrara, Italy.

View Article and Full-Text PDF
September 2014

[Current therapeutic indications of thalidomide and lenalidomide].

Med Clin (Barc) 2014 Apr 3;142(8):360-4. Epub 2013 Jul 3.

Servicio de Clínica Médica, Hospital Provincial del Centenario, Facultad de Ciencias Médicas, Universidad Nacional de Rosario, Rosario, Argentina.

Thalidomide is a synthetic glutamic acid derivative first introduced in 1956 in Germany as an over the counter medications. It was thought to be one of the safest sedatives ever produced as it was effective in small doses, was not addictive, and did not have acute side-effects such as motor impairment, but was quickly removed from market after it was linked to cases of severe birth defects. The Food and Drug Administration approved use in the treatment of erythema nodosum leprosum. Read More

View Article and Full-Text PDF

The efficacy of pulsed dye laser treatment for inflammatory skin diseases: a systematic review.

J Am Acad Dermatol 2013 Oct 24;69(4):609-615.e8. Epub 2013 May 24.

Department of Dermatology, Amphia Hospital Breda, Breda, The Netherlands. Electronic address:

Background: The position of the pulsed dye laser (PDL) in the treatment of inflammatory skin diseases is still unclear. Evidence-based recommendations are lacking.

Objectives: We sought to systematically review all available literature concerning PDL treatment for inflammatory skin diseases and to propose a recommendation. Read More

View Article and Full-Text PDF
October 2013

[Palpable arciforme migratory erythema].

Hautarzt 2012 Dec;63(12):965-8

Klinik für Dermatologie, Allergologie und Phlebologie, Klinikum Bremerhaven Reinkenheide, Postbrookstr. 103, 27574, Bremerhaven, Deutschland.

A 39-year-old man presented with an annular clearly palpable erythema on the décolleté. Based on clinical and histopathological findings, palpable migratory arciform erythema was diagnosed. This skin condition is classified as a rare type of T-cell pseudolymphoma. Read More

View Article and Full-Text PDF
December 2012

Photodynamic therapy: new treatment for refractory lymphocytic infiltration of the skin.

Clin Exp Dermatol 2012 Apr 2;37(3):235-7. Epub 2012 Feb 2.

Department of Dermatology, Chung-Ang University College of Medicine, Seoul, South Korea.

Lymphocytic infiltration of the skin (LIS) is a relatively uncommon skin condition, first described by Jessner and Kanof in 1953. LIS presents mainly on the face, in particular on the cheeks and earlobe, but also on the neck, upper trunk or proximal limbs of middle-aged adults. LIS is often resistant to treatment. Read More

View Article and Full-Text PDF

Familial benign chronic pemphigus (Hailey-Hailey Disease): use of topical immunomodulators as a modern treatment option.

Rev Med Chil 2011 May 16;139(5):633-7. Epub 2011 Sep 16.

Department of Dermatology and Venereology, Medical Faculty, Trakian University of Stara Zagora, Bulgaria.

Benign chronic familial pemphigus (Hailey-Hailey disease) is a rare autosomal dominant blistering skin disorder characterized by suprabasal cell separation (acantholysis) of the epidermis. The Hailey brothers first described it in 1939. Hailey-Hailey disease usually appears in the third or fourth decade, although it can occur at any age. Read More

View Article and Full-Text PDF

[An atypical presentation of primary cutaneous diffuse B-cell lymphoma, leg type].

Ann Dermatol Venereol 2011 Aug-Sep;138(8-9):601-4. Epub 2011 Apr 23.

Service de dermatologie, hôpital Fournier, CHU de Nancy, 36, quai de la Bataille, 54035 Nancy cedex, France.

Background: Primary cutaneous diffuse B-cell lymphoma, leg type, are rare and aggressive tumours frequently affecting elderly patients. We present a case of a 53-year-old woman with an atypical presentation of primary cutaneous diffuse B-cell lymphoma, leg type.

Case Report: Eight years after complete excision of a Jessner-Kanof lymphocytic infiltration on the right shoulder, the patient developed a primary cutaneous diffuse B-cell lymphoma, leg type at the same site. Read More

View Article and Full-Text PDF
January 2012

[Pulsed dye laser treatment for Jessner's lymphocytic infiltration of the skin].

Authors:
J-L Michel D Perrin

Ann Dermatol Venereol 2010 Dec;137(12):803-7

Cabinet de Dermatologie, Avenue Résidence v, 14, Place des Grenadiers-quartier-grouchy, 42000 Saint-Étienne, France.

Background: Jessner's lymphocytic infiltration of the skin (LIS) is a chronic, benign T-cell infiltrative disorder, usually manifesting as erythematous papules or plaques on the face, neck and back.

Patients And Methods: five patients presented LIS with numerous skin lesions on the face and back characteristic of this disease. Histological examination showed a lymphocytic infiltrate in the dermis without any modification of the epidermis. Read More

View Article and Full-Text PDF
December 2010

Lymphocytic infiltration of the skin (Jessner-Kanof) but not reticular erythematous mucinosis occasionally represents clinical manifestations of Borrelia-associated pseudolymphoma.

Br J Dermatol 2009 Sep 26;161(3):583-90. Epub 2009 May 26.

Department of Dermatology, Friedrich-Schiller-University, Jena, Germany.

Background: Lymphocytic infiltration of the skin (LIS) and reticular erythematous mucinosis (REM) are characterized histologically by an inflammatory cutaneous lymphocytic infiltrate similar to the histological appearance of pseudolymphoma.

Objectives: To re-evaluate a large cohort of patients with the clinical and/or histological diagnosis or differential diagnosis of LIS and REM and to assess the evidence for infection with Borrelia.

Methods: Sixty-nine cases of LIS and 34 cases of REM were retrospectively investigated. Read More

View Article and Full-Text PDF
September 2009

The expanding spectrum of cutaneous borreliosis.

Authors:
K Eisendle B Zelger

G Ital Dermatol Venereol 2009 Apr;144(2):157-71

Department of Dermatology and Venerology, Innsbruck Medical University, Innsbruck, Austria.

The known spectrum of skin manifestations in cutaneous Lyme disease is continuously expanding and can not be regarded as completed. Besides the classical manifestations of cutaneous borreliosis like erythema (chronicum) migrans, borrelial lymphocytoma and acrodermatitis chronica atrophicans evidence is growing that at least in part also other skin manifestations, especially morphea, lichen sclerosus and cases of cutaneous B-cell lymphoma are causally related to infections with Borrelia. Also granuloma annulare and interstitial granulomatous dermatitis might be partly caused by Borrelia burgdorferi or similar strains. Read More

View Article and Full-Text PDF

Thalidomide: dermatological indications, mechanisms of action and side-effects.

Br J Dermatol 2005 Aug;153(2):254-73

Department of Dermatology, University of California, Irvine, Irvine, CA, USA.

Thalidomide was first introduced in the 1950s as a sedative but was quickly removed from the market after it was linked to cases of severe birth defects. However, it has since made a remarkable comeback for the U.S. Read More

View Article and Full-Text PDF

A review of 55 cases of cutaneous lymphoid hyperplasia: reassessment of the histopathologic findings leading to reclassification of 4 lesions as cutaneous marginal zone lymphoma and 19 as pseudolymphomatous folliculitis.

Hum Pathol 2005 May;36(5):505-11

Department of Pathology, Saitama Medical School, Iruma-gun, Japan.

To clarify the confusion surrounding the diagnosis of cutaneous lymphoid hyperplasia (CLH) that was formerly described as lymphadenosis benigna cutis, lymphocytoma cutis, or lymphocytic infiltration of Jessner and to assess whether newly recognized diagnoses, such as cutaneous marginal zone lymphoma and pseudolymphomatous folliculitis (PLF), may have been overlooked, we reexamined 55 Japanese cases of nonepidermotropic lymphoproliferative disorder that had previously been diagnosed as "cutaneous pseudolymphoma." In all these cases, the immunohistochemical expressions of CD1a, CD3, CD4, CD8, CD20, CD21, CD30, CD43, CD56, CD68, CD79a, kappa and lambda chains, S-100 protein, and latent membrane protein were assessed. In addition, in 13 cases the gene rearrangement of the immunoglobulin heavy chain was investigated using a polymerase chain reaction method. Read More

View Article and Full-Text PDF

Jessner-Kanof lymphocytic infiltration of the skin associated with glatiramer acetate.

Mult Scler 2005 Apr;11(2):245-8

Department of Neurology, University of Cologne, 50924 Cologne, Germany.

Glatiramer acetate (GLAT) is a well tolerated and safe immunomodulatory drug for the treatment of relapsing-remitting multiple sclerosis. The most commonly recognized side effects are localized injection site reactions consisting of pain, pruritus, mild erythema and induration, which sometimes persist for several days. We describe the first case of a biopsy-proven lymphocytic infiltration (T-cell pseudolymphoma) with the clinical appearance of a figured erythema on the ventrolateral thighs in the first four weeks under GLAT treatment, resolving without any evidence of recurrence despite ongoing therapy. Read More

View Article and Full-Text PDF

Familial lymphocytic infiltration of the skin: histochemical and molecular analysis in three brothers.

Dermatology 2002 ;204(1):12-6

Department of Dermatology, University Medical Center Benjamin Franklin, Free University of Berlin, Germany.

Background: Lymphocytic infiltration of the skin (Jessner and Kanof) is a T cell pseudolymphoma characterized by the occurrence of recurrent asymptomatic papules and plaques and by a coat-sleeve-like perivascular lymphoid infiltrate. Rarely, familial cases have been reported.

Objectives: Our study was performed to address the question of a genetic predisposition in a case of familial lymphocytic infiltration by histochemical and molecular analysis. Read More

View Article and Full-Text PDF

[Palpable migratory acriform erythema and lymphocytic infiltration of the skin--different presentations of the same entity?].

Hautarzt 1999 Apr;50(4):270-4

Abteilung für Dermatologie und Allergologie, Städt. Krankenhaus München-Schwabing, Akademisches Lehrkrankenhaus des Ludwig-Maximilians-Universität München.

Palpable arciform migratory erythema of Clark (PAME) has been described as a rare member in the group of T-cell pseudolymphoma. The clinical picture of infiltrated annular erythema developing into large migrating lesions with the trunk as predilection site is distinctive from other pseudolymphomas. Because of the very similar histology and immunohistochemistry in comparison to the more frequent lymphocytic infiltration of the skin of Jessner and Kanof (LIS) doubts have been raised about the existence of PAME as an unique entity. Read More

View Article and Full-Text PDF

Palpable migratory arciform erythema. Clinical morphology, histopathology, immunohistochemistry, and response to treatment.

Arch Dermatol 1997 Jun;133(6):763-6

Department of Dermatology, Universität-Krankenhaus Eppendorf, Hamburg,Germany.

Background: Palpable migratory arciform erythema is clinically characterized by sharply circumscribed, infiltrated erythematous patches that tend to spread irregularly, resulting in arciform morphologic features. The histopathologic features are characterized by a patchy inflammatory perivascular and periadnexal T-lymphocytic infiltrate throughout the dermis. The disease runs a chronic course and is rarely described in the literature. Read More

View Article and Full-Text PDF

Crossover study of thalidomide vs placebo in Jessner's lymphocytic infiltration of the skin.

Arch Dermatol 1995 Sep;131(9):1032-5

Dermatology Service, Hôpital Henri Mondor, Créteil, France.

Background And Design: An effective therapy is still unavailable for Jessner-Kanof lymphocytic infiltration of the skin. Thalidomide's efficacy was suggested in an open study. Twenty-eight patients were randomly assigned to receive thalidomide (100 mg/d) or placebo over a period of 2 months and were then switched to the other treatment. Read More

View Article and Full-Text PDF
September 1995

Immunohistochemical analysis of dermal mononuclear cell infiltrates in cutaneous lupus erythematosus, polymorphous light eruption, lymphocytic infiltration of Jessner, and cutaneous lymphoid hyperplasia: a comparative differential study.

J Cutan Pathol 1994 Oct;21(5):430-6

Department of Pathology, Chang Gung College of Medicine and Technology, Tao Yuan, Taiwan.

Cutaneous lupus erythematosus (LE), polymorphous light-eruption (PMLE), lymphocytic infiltration of Jessner (LIJ), and cutaneous lymphoid hyperplasia (CLH) are often difficult to differentiate from one another by light microscopic examination. We conducted an immunohistochemical analysis of the mononuclear cell infiltrates in 13 LE, 12 PMLE, 10 LIJ, and 13 CLH with various antibodies. Antibodies L26, UCHL1, and S100 achieved statistically significant differences among the four diseases, but because of the overlaps in the number of UCHL1(+) T cells and S100 protein (+) cells in individual cases, these two antibodies were not useful. Read More

View Article and Full-Text PDF
October 1994

Persistent indurated plaques of the face: a variant of Jessner's lymphocytic infiltrate?

Cutis 1994 Jan;53(1):49-52

University of Texas Southwestern Medical Center at Dallas, Division of Dermatopathology 75235-9072.

Lymphocytic infiltrates of the skin classically include a select number of diagnostic entities such as lupus erythematosus, gyrate erythema, polymorphous light eruption, lymphocytoma cutis, lymphocytic leukemia, and lymphocytic infiltrate of Jessner. We recently observed two patients with chronic inflammatory plaques of the face with histologic features of a lymphocytic infiltrate with unusual clinical features. Persistent indurated plaques of the face may be a manifestation of lymphocytic infiltration of the skin that could represent a variant of Jessner's lymphocytic infiltrate. Read More

View Article and Full-Text PDF
January 1994

Nonclonal lymphocytic proliferation in cutaneous lymphoid hyperplasia: a flow-cytometric and morphological analysis.

Dermatology 1992 ;185(2):113-9

Department of Pathology, John L. McClellan Memorial Veterans Administration Hospital, Little Rock, Ark. 72205.

Cutaneous lymphoid hyperplasia, follicular B cell pseudolymphoma or lymphadenosis benigna cutis and lymphocytic infiltration of Jessner-Kanof are a group of benign lymphoid hyperplastic disorders which usually involve the skin of the face or head and neck. These lesions may be difficult to differentiate from malignant lymphocytic lymphomas both morphologically and clinically. To evaluate whether quantitative flow-cytometric analysis and DNA ploidy determination of the lymphoid cells in the lesions would provide additional and more precise diagnostic parameters, we have correlatively analyzed a case by morphological, flow-cytometric and immunohistochemical methods. Read More

View Article and Full-Text PDF
December 1992